A Phase 1, Randomized, Open-Label, Crossover Study to Assess the Relative Bioavailability of Lesinurad/Allopurinol Fixed Dose Combination Tablets and Coadministered Lesinurad and Allopurinol Tablets and the Effect of Food on the Pharmacokinetics of Lesinurad/Allopurinol Fixed Dose Combination Tablets in Healthy Adult Male Subjects

Trial Profile

A Phase 1, Randomized, Open-Label, Crossover Study to Assess the Relative Bioavailability of Lesinurad/Allopurinol Fixed Dose Combination Tablets and Coadministered Lesinurad and Allopurinol Tablets and the Effect of Food on the Pharmacokinetics of Lesinurad/Allopurinol Fixed Dose Combination Tablets in Healthy Adult Male Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 21 Dec 2016

At a glance

  • Drugs Allopurinol/lesinurad (Primary) ; Allopurinol; Lesinurad
  • Indications Gout
  • Focus Pharmacokinetics
  • Sponsors Ardea Biosciences
  • Most Recent Events

    • 29 Aug 2016 Status changed from recruiting to completed.
    • 02 Dec 2015 Planned End Date changed from 1 Mar 2016 to 1 Jun 2016, according to ClinicalTrials.gov record.
    • 02 Dec 2015 Planned primary completion date changed from 1 Nov 2015 to 1 Mar 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top